Cahill Represents Lead Arrangers in New Term Loan for Capsugel Holdings US, Inc.
Date: 09/20/13
Cahill represented UBS and the other lead arrangers in connection with a new $906 million term loan and a repricing of the company’s revolving loans. Capsugel is a leading company in the healthcare space, providing innovative dosage solutions to clients at every stage of the dosage form development process. Capsugel is a portfolio company of KKR.